1. ANDA submissions--amendments to abbreviated new drug applications under GDUFA
« Previous |
1 - 10 of 115
|
Next »
Search Results
2. Acne vulgaris: establishing effectiveness of drugs intended for treatment
3. Administrative procedures for CLIA categorization: guidance for industry and Food and Drug Administration staff
4. Advancement of emerging technology applications for pharmaceutical innovation and modernization
5. Allergic rhinitis: developing drug products for treatment
6. Anthrax: developing drugs for prophylaxis of inhalational anthrax
7. Antibacterial therapies for patients with an unmet medical need for the treatment of serious bacterial diseases
8. Appropriate use of voluntary consensus standards in premarket submissions for medical devices: guidance for industry and Food and Drug Administration staff
9. Assessing user fees under the Prescription Drug User Fee Amendments of 2017
10. Assessing user fees under the biosimilar user fee amendments of 2017
